Evolution of Diabetes Technology
Authors:
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 49 (1) , 1-18
Abstract
No abstract availableKeywords
Funding Information
- Abbott
- Medtronic
- Novo Nordisk
- GluSense
- Sanofi
- Sandoz
- Diamyd
This publication has 101 references indexed in Scilit:
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Insulin Pump Therapy With Automated Insulin Suspension in Response to HypoglycemiaDiabetes Care, 2011
- MD-Logic Artificial Pancreas SystemDiabetes Care, 2010
- Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 DiabetesDiabetes Care, 2009
- Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetesPediatric Diabetes, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008
- Use of Insulin Pump Therapy in the Pediatric Age-GroupDiabetes Care, 2007
- Glycemic and Risk Factor Control in Type 1 DiabetesDiabetes Care, 2007
- Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialThe Journal of Pediatrics, 1994